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Dear Editor, 
We read the article recently published by Sluka and colleagues1 in Physical Therapy with 
great interest. The elements raised by the authors shed important light on the mixed results 
obtained in the literature concerning the analgesic effect of transcutaneous electrical nerve 
stimulation (TENS). In their article, Sluka and colleagues identified many factors that can affect 
TENS efficacy. We would like to take this opportunity to highlight three other important 
elements than can affect the analgesic effect of TENS, and to remind physical therapists of the 
importance of considering these elements in their day-to-day practice. 
1) Caffeine consumption 
In 1995, Marchand and colleagues demonstrated that caffeine could block the analgesic effect 
of high-frequency TENS.2 Monitoring caffeine intake before treatment is essential if we want 
to maximize the analgesic effect of TENS. This obviously includes coffee, but also other 
sources of caffeine (e.g., tea, chocolate, energy drinks). Surprisingly, very few TENS studies 
published since 1995 have monitored caffeine consumption, a situation which is particularly 
problematic when we consider that individuals with certain chronic pain conditions tend to 
consume high quantities of caffeine.3 The half-life of caffeine is 4-6 hours.4 To assure optimal 
efficacy, TENS treatment should be delayed for 6 hours after caffeine intake. 
2) Electrodes placement 
To maximize TENS analgesia, the experimenter needs to ensure good positioning of the 
electrodes. Current norms in research often encourage researchers to use a single and 
standardized electrode position for all patients. However, in order to be effective, electrode 
placement should be adapted individually, based on the location of the patient’s pain.5, 6 
Electrode placement is especially important when using high-frequency TENS, a type of 
TENS which produces analgesia via local/segmental mechanisms.7 In such situations, the 
experimenter needs to be sure that the TENS-induced paresthesia appropriately covers the 
entire painful region. 
3) Pain intensity 
In 1997, Benedetti and colleagues8 showed that patients with severe pain responded less 
positively to TENS stimulations compared to patients with mild or moderate pain. These 
observations indicate that the intensity of clinical pain greatly affects the efficacy of TENS. 
Choice of the proper treatment must be done while taking in consideration the patient’s 
individual characteristics. TENS might not be the best treatment option for patients with high 
levels of pain.  
Clinical implications 
Ensuring proper positioning of the electrodes and screening for caffeine consumption requires 
time. With their busy daily schedules, physical therapists may tend to neglect these crucial steps. 
They must nevertheless remember that TENS, just like many other treatment modalities used in 
rehabilitation, requires time in order to be properly administered. By discarding certain essentials 
steps, physical therapists run the risk of affecting negatively and lastingly the efficacy of TENS 
treatments.9, 10 
In their article, Sluka and colleagues observed that the timing of assessment is another 
important issue which could account for the mixed results observed in the literature. We agree 
with the arguments raised by the authors: the effect of TENS, just like the effect of any other 
given intervention, should be measured during peak effect. The authors noted that the analgesic 
effect of TENS is maximal during TENS stimulation, an observation which was also reported by 
Wall & Sweet in 1967 in one of the first studies published on TENS.6 In addition to being 
important to research, this observation bears important consideration in clinical settings. 
Specifically, in patients with chronic pain, TENS should rarely (if ever) be used solely in clinic. 
Instead, chronic pain patients should be taught how to use TENS at home; a strategy that will 
allow these patients to take full advantage of the analgesic effect of TENS therapy. 
Conclusion 
Several factors must be considered when using TENS. These factors include the intensity 
of the TENS stimulation, its interaction with pharmacological and non-pharmacological agents, 
the target population, the outcomes measured, the study design and the patient’s characteristics. 
We wish to thank Sluka and colleagues for their commendable article and hope that the elements 
raised by these authors, as well as the subject discussed in the present paper, will contribute to a 
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